Probiotics in human disease - PubMed (original) (raw)
Review
. 2001 Jun;73(6):1142S-1146S.
doi: 10.1093/ajcn/73.6.1142S.
Affiliations
- PMID: 11393192
- DOI: 10.1093/ajcn/73.6.1142S
Review
Probiotics in human disease
E Isolauri. Am J Clin Nutr. 2001 Jun.
Abstract
Western civilization is facing a progressive increase in immune-mediated, gut-related health problems, such as allergies and autoimmune and inflammatory diseases, and genetic factors are an unlikely explanation for these rapid increases in disease incidence. Two environmental factors that relate to the modern lifestyle in Western societies are hygiene and nutrition. There has been a decline in the incidence of microbial stimulation by infectious diseases as a result of improved hygiene, vaccination, and antimicrobial medication. In the past, methods of food preservation involved either the natural fermentation or drying of foods; thus, the human diet once contained several thousand times more bacteria than it does today. The development of probiotic, functional foods aims to "kill two birds with one stone," which is accomplished by providing a microbial stimulus to the host immune system by means of beneficial live microorganism cultures that are characteristic of the healthy, human gut microflora, ie, probiotics. Probiotic bacteria were shown to reinforce the different lines of gut defense, which are immune exclusion, immune elimination, and immune regulation. They were also shown to stimulate nonspecific host resistance to microbial pathogens, thereby aiding in pathogen eradication. Consequently, the best documented clinical application of probiotics is in the treatment of acute diarrhea. In humans, documented effects were reported for the alleviation of intestinal inflammation, normalization of gut mucosal dysfunction, and down-regulation of hypersensitivity reactions. These data show that probiotics promote endogenous host defense mechanisms. Thus, modification of gut microflora by probiotic therapy may offer a therapeutic potential in clinical conditions associated with gut-barrier dysfunction and inflammatory response.
Similar articles
- Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
Isolauri E, Salminen S; Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report. Isolauri E, et al. J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S91-6. doi: 10.1097/MCG.0b013e3181639a98. J Clin Gastroenterol. 2008. PMID: 18542035 Review. - Immunobiotics and the probiotic evolution.
Clancy R. Clancy R. FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):9-12. doi: 10.1016/S0928-8244(03)00147-0. FEMS Immunol Med Microbiol. 2003. PMID: 12900049 Review. - The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease.
Rautava S, Isolauri E. Rautava S, et al. Curr Issues Intest Microbiol. 2002 Mar;3(1):15-22. Curr Issues Intest Microbiol. 2002. PMID: 12022809 - Probiotics, prebiotics, and synbiotics.
de Vrese M, Schrezenmeir J. de Vrese M, et al. Adv Biochem Eng Biotechnol. 2008;111:1-66. doi: 10.1007/10_2008_097. Adv Biochem Eng Biotechnol. 2008. PMID: 18461293 Review. - Probiotics: effects on immunity.
Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Isolauri E, et al. Am J Clin Nutr. 2001 Feb;73(2 Suppl):444S-450S. doi: 10.1093/ajcn/73.2.444s. Am J Clin Nutr. 2001. PMID: 11157355 Review.
Cited by
- Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives.
Nahm DH. Nahm DH. Life (Basel). 2023 Aug 1;13(8):1674. doi: 10.3390/life13081674. Life (Basel). 2023. PMID: 37629531 Free PMC article. Review. - Bacillus pumilus TS1 alleviates Salmonella Enteritidis-induced intestinal injury in broilers.
Liu Y, Li Z, Li H, Wan S, Tang S. Liu Y, et al. BMC Vet Res. 2023 Feb 10;19(1):41. doi: 10.1186/s12917-023-03598-0. BMC Vet Res. 2023. PMID: 36759839 Free PMC article. - Systematic comparison of transcriptomes of Caco-2 cells cultured under different cellular and physiological conditions.
Elzinga J, Grouls M, Hooiveld GJEJ, van der Zande M, Smidt H, Bouwmeester H. Elzinga J, et al. Arch Toxicol. 2023 Mar;97(3):737-753. doi: 10.1007/s00204-022-03430-y. Epub 2023 Jan 21. Arch Toxicol. 2023. PMID: 36680592 Free PMC article. - Limosilactobacillus reuteri in Health and Disease.
Abuqwider J, Altamimi M, Mauriello G. Abuqwider J, et al. Microorganisms. 2022 Feb 28;10(3):522. doi: 10.3390/microorganisms10030522. Microorganisms. 2022. PMID: 35336098 Free PMC article. Review. - Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea.
Li YD, Liu BN, Zhao SH, Zhou YL, Bai L, Liu EQ. Li YD, et al. World J Gastroenterol. 2021 Feb 7;27(5):391-403. doi: 10.3748/wjg.v27.i5.391. World J Gastroenterol. 2021. PMID: 33584071 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous